The Informatics Core develops and supports informatics applications and shared informatics resources forCancer Center investigators. Many Cancer Center programs and cores have projects requiring complexinformation systems, including tissue and specimen tracking, related clinical and patient follow-upinformation, clinical trials data management, microarray data and metadata management and analysis.
The aims of the Core are to develop, deploy, and maintain data systems and applications to directly supportthe translational research goals of the Center. The Core develops data systems that span a range of users,from individual investigators, to individual programs within the Cancer Center, and to the Cancer Center as awhole. It works with researchers, Cancer Center administration, and other cores to fulfill its goals.Services of the Core include: (1) design and implementation of data models, (2) design and implementationof user interfaces, (3) maintenance of databases and associated web sites, and (4) custom data servicesinvolving specific programming expertise. These capabilities are offered on a recharge basis, both for shortand long-term projects.PERFORMANCE SITE(S) (organization, city, state)UCSF Comprehensive Cancer CenterSan Francisco, CaliforniaPHS 398 (Rev. 04/06) - Page 2 Form Page 2PHS 398/2590 (Rev. 09/04) Page 1 1 O 1 Informatics
| Sannino, Sara; Guerriero, Christopher J; Sabnis, Amit J et al. (2018) Compensatory increases of select proteostasis networks after Hsp70 inhibition in cancer cells. J Cell Sci 131: |
| Lam, Christine; Ferguson, Ian D; Mariano, Margarette C et al. (2018) Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment. Haematologica 103:1218-1228 |
| Truillet, Charles; Parker, Matthew F L; Huynh, Loc T et al. (2018) Measuring glucocorticoid receptor expression in vivo with PET. Oncotarget 9:20399-20408 |
| Phillips, Kathryn A; Trosman, Julia R; Deverka, Patricia A et al. (2018) Insurance coverage for genomic tests. Science 360:278-279 |
| Phillips, Kathryn A (2018) Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning? JAMA 319:2379-2380 |
| Puri, Sapna; Roy, Nilotpal; Russ, Holger A et al. (2018) Replication confers ? cell immaturity. Nat Commun 9:485 |
| An, Zhenyi; Aksoy, Ozlem; Zheng, Tina et al. (2018) Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene 37:1561-1575 |
| Behr, Spencer C; Villanueva-Meyer, Javier E; Li, Yan et al. (2018) Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MR. JCI Insight 3: |
| Rubenstein, James L; Geng, Huimin; Fraser, Eleanor J et al. (2018) Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma. Blood Adv 2:1595-1607 |
| An, Zhenyi; Knobbe-Thomsen, Christiane B; Wan, Xiaohua et al. (2018) EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma. Cancer Res 78:6785-6794 |
Showing the most recent 10 out of 192 publications
